Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Memantine cost saving for AD in Finland

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Memantine cost saving for AD in Finland. Pharmacoecon. Outcomes News 457, 7 (2004). https://doi.org/10.2165/00151234-200404570-00015

    Download citation

    Keywords

    • Placebo
    • Cost Saving
    • Markov Model
    • Memantine
    • Informal Care